Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at a significant discount to what it’s worth. The product is held in high regard by those in the industry, who […]
There is no excerpt because this is a protected post.
GeoTeam Looking to Trade Hemispherx Biopharma (HEB) ($0.35) on Chardan Update The Geoteam will look to trade HEB due to Chardan Capital pitching the company as an EBOLA play with a $3 price target. “Chardan Capital affirms its Buy rating […]
Xpel Technlogies (XPLT) ($3.00) – Adding to Long Position Our long position was established in 1/18/2013 at $0.29 and we are coding XPLT as a GeoBargain. Our due diligence indicates XPLT is about to take second leg up in its growth […]
Call to Action, Long: Xpel Technlogies (XPLT) – We will look to add to our position. Adding to our long position in XPLT ($3.00) established on 1/18/2013 at $0.29 and coding as GeoBargain. Our due diligence indicates XPLT is about to […]
On 7/14/2014 we stated “CREG has entered into an equity line of credit with an entity (Ya Global) where it could potentially sell $50 million worth of shares over a 2 year period of time at prices yet to be […]
Call(s) to Action: CREG Long: None Short: CREG ($1.27) – On 7/14/2014 we stated “CREG has entered into an equity line of credit with an entity (Ya Global) where it could potentially sell $50 million worth of shares over a […]
Summary: 344 days of time-lapse surveillance of CGA’s high-margin Jinong fertilizer factory, contributing 75% of CGA’s gross profit, shows it only shipped around 10% of the volume CGA reports it sold. 51 days of time-lapse surveillance of CGA’s low-margin Gufeng […]